I-Corps: A digital health diagnostic technology that provides a multilingual, multimodal, and multidimensional pain management tool

这个I-Corps项目的更广泛的影响/商业潜力- CIPDAR（文化知情的疼痛诊断和缓解）-可能是三重的。 第一个好处是通过改善英语水平有限（LEP）慢性疼痛患者与医疗保健提供者之间的口头和非口头沟通来减少健康差异，从而提高诊断准确性并改善治疗效果。 其次是节省时间和金钱，因为提高诊断准确性可以消除不必要的测试，并在更短的时间内制定更有效的治疗计划。第三个好处是具有成本效益的适应其他疾病，如慢性阻塞性肺病，糖尿病和癌症。CIPDAR还将为疼痛科学以及健康传播增加重要知识，包括管理和诊断最佳实践。通过纳入文化规范和其他语言的流利性，CIPDAR不仅可以重新吸引被剥夺权利的LEP患者，而且可以通过利用文化和语言信息内容和资源来提高他们对医疗保健系统的信任。慢性疼痛LEP患者的家庭也可以使用CIPDAR不仅帮助倡导他们所爱的人，但更好地了解他们的需求时，条件是无法治愈的。这个I-Corps项目，CIPDAR（文化知情疼痛诊断和救济），为有限的英语能力（LEP）慢性疼痛患者提供不仅仅是一个简单的翻译服务。使用以患者为中心的方法，它结合了特定文化的术语，短语和相关问题，以改善患者与提供者的沟通。所有功能都是由双语人士设计和编写的，确保患者获得准确的信息，也是文化和语言一致的。该技术整合了生物心理社会干预和技术，以更好地为LEP患者提供疼痛管理工具，例如教授时间管理，工作家庭平衡和药物跟踪的在线模块。CIPDAR不仅通过患者自我报告策略测量疼痛，还通过分析非语言行为（例如，手势、动作和面部表情），提供多个数据流以进行更明智的疼痛评估。通过提供生物心理社会干预沿着改善患者与提供者的沟通，CIPDAR将解决误诊、无效治疗和药物滥用的不利影响。它将使患有慢性疼痛的LEP患者能够为自己辩护，而不必依赖家庭成员担任翻译或简单的，文化上不知情的商业翻译。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impacts/commercial potential of this I-Corps project - CIPDAR (Culturally Informed Pain Diagnosis and Relief) - are potentially three-fold. The first benefit is a reduction in health disparities by improving both verbal and non-verbal communication between Limited English Proficiency (LEP) chronic pain patients and healthcare providers, resulting in greater diagnostic accuracy and improved treatment outcomes. The second is savings in time and money as improved diagnostic accuracy can eliminate unnecessary testing and lead to more effective treatment plans over shorter timespans. The third benefit is cost-effective adaptability to other diseases, such as chronic obstructive pulmonary disease, diabetes, and cancer. CIPDAR will also add significant knowledge to pain science, as well as health communication, including management and diagnostic best practices. By including cultural norms and fluency in other languages, CIPDAR can not only re-engage disenfranchised LEP patients, but improve their trust in the healthcare system by leveraging culturally and linguistically informed content and resources. The families of chronic pain LEP patients can also use CIPDAR to not only help advocate for their loved ones, but to better understand their needs when a condition has no cure.This I-Corps project, CIPDAR (Culturally Informed Pain Diagnosis and Relief), offers more than a simple translation service for Limited English Proficiency (LEP) chronic pain patients. Using a patient-centered approach, it incorporates culturally specific terms, phrases, and relevant questions to improve patient-provider communication. All features are designed and written by bilingual individuals, ensuring that patients receive accurate information that is also culturally and linguistically congruent. The technology integrates biopsychosocial interventions and techniques to better equip LEP patients with pain management tools, such as online modules that teach time management, work-family balance, and medication tracking. CIPDAR not only measures pain via patient self-reporting strategies, but also by analyzing non-verbal behaviors (e.g., gestures, movements, and facial expressions), providing multiple data streams for more informed pain assessments. By offering biopsychosocial interventions along with improved patient-provider communication, CIPDAR will address the detrimental effects of misdiagnosis, ineffective treatment, and medication misuse. It will empower LEP patients with chronic pain to advocate for themselves without having to rely on family members acting as translators or on simple, culturally-uninformed commercial translations.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.